Citation Impact

1 from Science/Nature 57 standout
Sub-graph 1 of 21

Citing Papers

Diagnosis and Treatment of Metastatic Colorectal Cancer
2021 Standout
Targeting metastatic cancer
2021 Standout
2 intermediate papers

Works of J. Bernhard being referenced

Prevention of symptomatic skeletal events with denosumab administered every 4 weeks versus every 12 weeks: A noninferiority phase III trial (SAKK 96/12, REDUSE).
2014
Prevention of Symptomatic Skeletal Events with Denosumab Administered Every 4 Weeks Versus Every 12 Weeks–A Non-Inferiority Phase III Trial: Sakk 96/12 - Reduse
2014
and 1 more

Author Peers

Author Oncology PRM PPCH Cancer Research Last Decade Papers Cites
J. Bernhard 503 441 76 147 36 1.1k
Linda M. Kallinen 1 11 1 14 874
Harald Holone 1 6 79
John Tisdale 6 226
Che Lin 101 22 2 91 20 360
Maria Costa 2 11 23 395

All Works

Loading papers...

Rankless by CCL
2026